title: Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.
authors.forename: Sangam
authors.initials: S
authors.lastname: Hebballi
authors.forename: Susanna
authors.initials: S
authors.lastname: Akiki
authors.forename: David
authors.initials: D
authors.lastname: Bareford
mesh_terms: D001856:Bone Marrow Examination; D004252:DNA Mutational Analysis; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D053614:Janus Kinase 2 / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D011087:Polycythemia Vera / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007155:Immunologic Factors; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D013792:Thalidomide; C507924:JAK2 protein, human; D053614:Janus Kinase 2; C100416:peginterferon alfa-2a